Richard Whelan MD
Associate Clinical Professor of Surgery, Columbia P&S
Join to View Full Profile
122 East 76th StreetSuite 1BNew York, NY 10021
Phone+1 212-434-4860
Dr. Whelan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MinnesotaResidency, Colon and Rectal Surgery, 1987 - 1988
New York Presbyterian Hospital (Columbia Campus)Residency, Surgery, 1982 - 1987
Columbia University Vagelos College of Physicians and SurgeonsClass of 1982
Certifications & Licensure
NY State Medical License 1985 - 2027
MN State Medical License 1987 - 1988
American Board of Colon and Rectal Surgery Colon & Rectal Surgery
Clinical Trials
- PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer Start of enrollment: 2020 Aug 21
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Management of Peritoneal Metastasis in Patients with Pancreatic Ductal Adenocarcinoma.Grace Wu, Oliver J Standring, Daniel A King, Sepideh Gholami, Craig E Devoe
Current Oncology. 2025-02-12 - ASO Visual Abstract: Impact of PIPAC-Oxaliplatin on Functional Recovery, Good Days, and Survival in Refractory Colorectal and Appendiceal Carcinomatosis-Secondary Anal...Muhammad Talha Waheed, Nora Ruel, Richard L Whelan, Marwan Fakih, Yuman Fong
Annals of Surgical Oncology. 2025-02-01 - 1 citationsImpact of PIPAC-Oxaliplatin on Functional Recovery, Good Days, and Survival in a Refractory Colorectal and Appendiceal Carcinomatosis: Secondary Analysis of the US PIP...Muhammad Talha Waheed, Nora Ruel, Richard L Whelan, Marwan Fakih, Yuman Fong
Annals of Surgical Oncology. 2024-11-01
Press Mentions
- LI Cancer Patient First in NYS to ReceiveMarch 8th, 2021
- The Cancer Testis Antigens CABYR-a/b and CABYR-C Are Expressed in a Subset of Colorectal Cancers and Hold Promise as Targets for Specific ImmunotherapyMarch 2nd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
